SCHEMBL6163911

SCHEMBL6163911

CC1(C)Cc2c(c(-c3ccccc3)nn2-c2nc3ccccc3s2)C(=O)C1C#N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.42
ALDH1A1 P00352 4/20 0.42
NPSR1 Q6W5P4 4/20 0.42
TP53 P04637 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
MAPK1 P28482 2/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
KDM4E B2RXH2 3/20 0.40
SLC11A2 P49281 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
HSD17B10 Q99714 2/20 0.36
THRB P10828 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164597 0.94 NPC1 (0.36) MAPTALDH1A1NPSR1TP53SMN1; SMN2
SCHEMBL6166806 0.91 APP (0.39) MAPTALDH1A1NPSR1TP53SMN1; SMN2
SCHEMBL6166598 0.89 PDE10A (0.47) MAPTALDH1A1NPSR1TP53SMN1; SMN2
SCHEMBL6166432 0.88 TP53 (0.35) MAPTALDH1A1NPSR1TP53SMN1; SMN2
SCHEMBL6162645 0.88 LMNA (0.41) MAPTALDH1A1NPSR1TP53SMN1; SMN2
SCHEMBL6166932 0.88 RAB9A (0.36) MAPTALDH1A1NPSR1TP53SMN1; SMN2
SCHEMBL6164872 0.88 ALDH1A1 (0.35) MAPTALDH1A1NPSR1TP53SMN1; SMN2
SCHEMBL6167088 0.88 TP53 (0.34) MAPTALDH1A1NPSR1TP53SMN1; SMN2
SCHEMBL6165463 0.88 RAB9A (0.41) MAPTALDH1A1NPSR1TP53SMN1; SMN2
SCHEMBL6183323 0.86 ALDH1A1 (0.37) MAPTALDH1A1NPSR1TP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed